These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 5785943)

  • 1. [On the variability of yeast fungi of species Candida under effect of sodium salt of levorin].
    Egorenkova AN
    Antibiotiki; 1969 May; 14(5):430-2. PubMed ID: 5785943
    [No Abstract]   [Full Text] [Related]  

  • 2. [Characteristics of yeast-like fungi of Candida species isolated from patients in the process of treatment with levorin preparations].
    Egorenkova AN; Iarobkova ND
    Antibiotiki; 1968 Feb; 13(2):181-5. PubMed ID: 5667948
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of the cultivation conditions of Candida species yeast-like fungi on their sensitivity to levorin].
    Vasil'eva NG; Fradkova TA; Golubkova LS
    Antibiotiki; 1977 May; 22(5):433-7. PubMed ID: 327914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of resistance by candida species to polyene antibiotics in vitro.
    Athar MA; Winner HI
    J Med Microbiol; 1971 Nov; 4(4):505-17. PubMed ID: 5316339
    [No Abstract]   [Full Text] [Related]  

  • 5. [In vitro resistance of Candida species to antifungal agents].
    Banach-Piatkowska W; Kotłowski A; Humanowska J; Mayer L; Kowalczyk D
    Wiad Parazytol; 2001; 47(4):811-6. PubMed ID: 16886432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Moronal sensitivity of 590 yeasts and yeast-like fungi from fecal specimen of patients with gastrointestinal disturbances].
    Abou-Gabal M; Zoric V
    Mykosen; 1969 Jan; 12(1):77-80. PubMed ID: 5407929
    [No Abstract]   [Full Text] [Related]  

  • 7. [Induction of resistance of yeast-like fungi to synthetic antifungal agents].
    Pawlik B; Hołuj-Gubała J; Dźwigaj-Stokłosa W
    Med Dosw Mikrobiol; 1983; 35(1):43-8. PubMed ID: 6633032
    [No Abstract]   [Full Text] [Related]  

  • 8. [Routine application of serologic typing and in vitro tests of antifungal activity in vaginal mycosis].
    Perini M; Tampieri M; Rota G
    Quad Sclavo Diagn; 1983 Dec; 19(4):463-71. PubMed ID: 6677939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Boric acid, borax and moronal. Comparative evaluation of the inhibitory effect on the causative agent of thrush].
    Rieth H; Kejda J
    Mykosen; 1968 Sep; 11(9):659-64. PubMed ID: 5761194
    [No Abstract]   [Full Text] [Related]  

  • 10. [Candida krusei (Castellani) Berkhout--a potential pathogen with growing importance].
    Otcenásek M; Buchta V
    Epidemiol Mikrobiol Imunol; 1998 Dec; 47(4):137-40. PubMed ID: 9919813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapeutic effect of the cholesterin-levorin complex].
    Klimov AN; Nikiforova AA
    Antibiotiki; 1971 Feb; 16(2):120-2. PubMed ID: 5557385
    [No Abstract]   [Full Text] [Related]  

  • 12. Update on clinical antifungal susceptibility testing for Candida species.
    Lewis RE; Klepser ME; Pfaller MA
    Pharmacotherapy; 1998; 18(3):509-15. PubMed ID: 9620102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of in vitro antifungal susceptibility testing.
    Espinel-Ingroff A
    Rev Esp Quimioter; 2000 Jun; 13(2):161-6. PubMed ID: 10918088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sensitivity of Candida strains isolated from bile to some antifungal antiobiotics from the polyene group].
    Lipnicki D; Zamiechowska-miazga J
    Pol Tyg Lek; 1975 Jan; 30(2):49-51. PubMed ID: 1110938
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid identification of fluconazole resistance using Chromagar Candida.
    Verghese SL; Padmaja P; Sutha P; Mathew T; John ES
    Indian J Pathol Microbiol; 2000 Jul; 43(3):343-6. PubMed ID: 11218683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of a new automated system for the determination of antifungal sensitivity].
    Lozano MC; Parras P; Martín E
    Enferm Infecc Microbiol Clin; 1993 Mar; 11(3):135-8. PubMed ID: 8499512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the pink, adenine-deficient strains of Candida albicans. I. Cultural and morphological characteristics.
    Chung KJ; Hill WB
    Sabouraudia; 1970 May; 8(1):48-59. PubMed ID: 5427154
    [No Abstract]   [Full Text] [Related]  

  • 18. Induced resistance of C. albicans strains to sodium salt of N-succinyl perimycin.
    Michalska-Trenkner E
    Chemotherapy; 1970; 15(1):19-25. PubMed ID: 5437400
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro activity of 6 antifungal agents on candida species isolated as causative agents from vaginal and other clinical specimens.
    Ellabib MS; ElJariny IA
    Saudi Med J; 2001 Oct; 22(10):860-3. PubMed ID: 11744942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.
    Pfaller MA; Diekema DJ; Gibbs DL; Newell VA; Meis JF; Gould IM; Fu W; Colombo AL; Rodriguez-Noriega E;
    J Clin Microbiol; 2007 Jun; 45(6):1735-45. PubMed ID: 17442797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.